Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Monday, April 28, 2025 · 807,494,300 Articles · 3+ Million Readers

Claritas Rx Launches First and Only Care Coordination Platform for Specialty and Rare Disease Patients

April 28, 2025 --

ASEMBIA AXS25Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announced today the availability of Patient Watchtower, the first and only care coordination platform for specialty and rare disease patients. SaaS-based Patient Watchtower seamlessly merges complex and fragmented patient data from various sources and creates immediate actionable insights. It uses artificial intelligence and machine learning (AIML) to enable precise patient microtargeting based on risk factors, ensuring the patient will receive prompt treatment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428746694/en/

“Hyper-targeted coordination of disparate groups within a health enablement and access team (HEAT) allows biopharma companies to potentially increase their fill rate by 20%. For many specialty brands, this type of uplift can mean millions of dollars and more importantly, getting treatment to a patient faster,” said Mike Fitzgibbons, CEO of Claritas Rx. “Patient Watchtower gives life sciences companies unprecedented visibility into the prescription process, allowing them to quickly identify access issues and suggest the next best action to help patients start and stay on treatment.”

“Hyper-targeted coordination of disparate groups within a health enablement and access team (HEAT) allows biopharma companies to potentially increase their fill rate by 20%. For many specialty brands, this type of uplift can mean millions of dollars and more importantly, getting treatment to a patient faster,” said Mike Fitzgibbons, CEO of Claritas Rx. “Patient Watchtower gives life sciences companies unprecedented visibility into the prescription process, allowing them to quickly identify access issues and suggest the next best action to help patients start and stay on treatment.”

Patient Watchtower manages the health enablement and access team (HEAT) of a patient, including case managers, specialty pharmacies, field teams, HUBs, other patient support call centers and any other resources biopharma companies would want to include. This coordination enables biopharma companies to leverage real-world, first-party data from care coordination organizations, making it instantly actionable for initiating patient support and interventions.

“Hyper-targeted coordination of disparate groups within a health enablement and access team (HEAT) allows biopharma companies to potentially increase their fill rate by 20%. For many specialty brands, this type of uplift can mean millions of dollars and more importantly, getting treatment to a patient faster,” said Mike Fitzgibbons, CEO of Claritas Rx. “Patient Watchtower gives life sciences companies unprecedented visibility into the prescription process, allowing them to quickly identify access issues and suggest the next best action to help patients start and stay on treatment.”

Specifically designed for Patient Services teams, Patient Watchtower offers:

  • Tailored at-a-glance patient journey dashboard – customized to how the company envisions the patient journey
  • Daily status updates providing Patient Services Teams visibility to high-priority patient cases requiring immediate attention
  • Instant access to a patient’s detailed case history
  • Shareable real-time information, enabling collaboration with partners
  • Predictive analytics using machine learning on patient risk factors such as prescription discontinuation and abandonment

Webinar: Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence

Claritas Rx is offering a webinar entitled “Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence” that will include a detailed overview of Patient Watchtower.

When: May 15, 2025, at 1:00 p.m. ET (10:00 a.m. PT)

Where: Virtual – click here to register: Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence

Who: Presented by Stuart Kamin, SVP, Analytics and Innovation at Claritas Rx and Karishma Desai, Solutions Consulting Engineer at Claritas Rx.

Media can RSVP to the webinar by contacting Elizabeth Marshall at emarshall@claritasrx.com.

About Patient Watchtower on the Claritas Rx Ascend ™ Platform

Patient Watchtower is part of the Claritas Rx Ascend™ platform. The Ascend platform allows seamless data input and set-up, simplifying patient risk assessments and intervention planning to optimize patient services. AIML is used for patient data management, strictly adhering to HIPAA, HITECH, GDPR and SOC2 regulations. Ascend utilizes hundreds of predictive factors to provide a comprehensive perspective for informed decision-making for Field Access Teams to take the next best action.

Patient Watchtower transforms raw data into actionable insights to uncover hidden narratives behind the data. With Patient Watchtower, companies can understand why a patient might drop off treatment and stay one step ahead in offering the help they need.

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx is a technology company focused on managing real world data focused on specialty biopharmaceutical distribution channels in oncology and rare/orphan diseases. Since 2011 the company has illuminated brand performance and the patient journey for dozens of therapies. Claritas Rx creates actionable business intelligence that helps manufacturers more effectively go to market and enhance the patient experience. For more information visit www.claritasrx.com.

Powered by EIN Presswire

Distribution channels:

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release